Publications by authors named "MS Anderson"

Claim this Profile
F
Fezf2 regulates differentiation of Aire-expressing and post-Aire mimetic epithelial populations maintaining thymic homeostasis.
Joe Germino, Xian Liu, Yi Wang, Jared Balolong, Vera Tang, Mark S Anderson

bioRxiv· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BCMA-directed mRNA CAR-T cell therapy for myasthenia gravis: exploratory biomarker analysis of a placebo-controlled phase 2b trial.
Renee R Fedak, Rachel N Ruggerie, Yufei Shan, Elizabeth J Curvino, Juliana F de Sousa, Mark S Anderson

Nat Med· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-perilipin-1 autoantibodies in autoimmune Addison's disease and related endocrine disorders.
Muhammad O Rahman, Andre Sulen, Lars Breivik, Silke Appel, Mark S Anderson

Autoimmunity· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic modeling and efficacy of ceftobiprole medocaril against pneumonic tularemia in cynomolgus macaques.
Mark M Hahn, Michael S Anderson, Matthew Snyder, Wantong Du, Ying-Liang Chou

Antimicrob Agents Chemother· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune Checkpoint Inhibitor-Induced Diabetes Across National Cancer Institute Trials That Included PD-1 or PD-L1 Agents.
Zoe E Quandt, Shanda Finnigan, Vanessa Hill, Joe E Dib, Jason Burian, Mark S Anderson

JAMA Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Active Antigen-Specific Adaptive Immune Responses Are Shared among Patients with Progressive Fibrotic Interstitial Lung Disease.
Tania E Velez, Young Me Yoon, Vaibhav Upadhyay, Sara E Vazquez, Cathryn T Lee, Mark S Anderson

Am J Respir Crit Care Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, tolerability, and pharmacokinetics of single and multiple ascending doses of zavegepant nasal spray in healthy adults from two phase 1 randomized, placebo-controlled trials.
Richard Bertz, Mary Donohue, Jennifer Madonia, Rajinder Bhardwaj, Kyle T Matschke, Matt S Anderson

Headache· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of optical photothermal infrared spectroscopy (O-PTIR) for future returned Mars samples.
Nicholas Heinz, Mark S Anderson, Jerami Mennella, George R Rossman

Rev Sci Instrum· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autoimmune origin for immune checkpoint inhibitor-diabetes revealed by deep immune phenotyping of the pancreas.
Zoe Quandt, Arabella Young, Graham Larson Barlow, Jennifer A Smith, Irina Kusmartseva, Mark S Anderson

J Immunother Cancer· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
External Validation of a Machine Learning Model to Diagnose Kawasaki Disease.
Jonathan Y Lam, Chisato Shimizu, Michael A Gardiner, Thomas Giorgio, Veronique Wright, Marsha S Anderson

J Pediatr· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Associations between immune checkpoint inhibitor response, immune-related adverse events, and steroid use in RADIOHEAD: a prospective pan-tumor cohort study.
Zoe Quandt, Anastasia Lucas, Samantha I Liang, EnJun Yang, Samantha Stone, Mark S Anderson

J Immunother Cancer· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of pharmacokinetic and pharmacodynamic interactions between zavegepant and sumatriptan: A phase 1, randomized, placebo-controlled study in healthy adults.
Rajinder Bhardwaj, Mary K Donohue, Jennifer Madonia, Kyle Matschke, Matt S Anderson

Headache· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Randomized, Double-Blind, Placebo-Controlled, Short-Term Monotherapy Study of MK-6186, an HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitor, in Treatment-Naïve HIV-Infected Participants.
Dirk Schürmann, Andreas Hüser, Frieder Pfäfflin, Caroline Cilissen, Inge De Lepeleire, Matt S Anderson

AIDS Res Hum Retroviruses· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nr4a1 and Nr4a3 redundantly control clonal deletion and contribute to an anergy-like transcriptome in auto-reactive thymocytes to impose tolerance in mice.
Hailyn V Nielsen, Letitia Yang, James L Mueller, Alexander J Ritter, Ryosuke Hiwa, Mark S Anderson

Nat Commun· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Repetitive Grooming Behavior Following Aversive Stimulus Coincides with a Decrease in Anterior Hypothalamic Area Activity.
Brenton T Laing, Megan S Anderson, Aishwarya Jayan, Anika S Park, Lydia J Erbaugh

eNeuro· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early expansion of TIGIT+PD1+ effector memory CD4 T cells via agonistic effect of alefacept in new-onset type 1 diabetes.
Lauren E Higdon, Laura A Cooney, Elisavet Serti, Duangchan Suwannasaen, Virginia S Muir, Mark S Anderson

J Immunol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deconvoluting zavegepant drug-drug interactions: A phase I study to evaluate the effects of rifampin and itraconazole on zavegepant pharmacokinetics.
Rajinder Bhardwaj, Jo Ann Malatesta, Jennifer Madonia, Matt S Anderson, Beth Morris

Clin Transl Sci· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monogenic Type 1 Diabetes: A High Yield Pool in Which to Discover New Mechanisms and Candidate Therapeutics for Type 1 Diabetes.
Chester E Chamberlain, Michael S German, Louis H Philipson, Mark S Anderson

Cold Spring Harb Perspect Med· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Altered Purinergic Signaling and CD8+ T Cell Dysregulation in STAT3 GOF Syndrome.
Jose S Campos Duran, Samir Sayed, Megan C Dalalo, Andrea A Mauracher, Montana S Knight, Mark S Anderson

bioRxiv· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incontinentia pigmenti underlies thymic dysplasia, autoantibodies to type I IFNs, and viral diseases.
Jérémie Rosain, Tom Le Voyer, Xian Liu, Adrian Gervais, Laura Polivka, Mark S Anderson

J Exp Med· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Etiology and Epidemiology of Travelers' Diarrhea among US Military and Adult Travelers, 2018-2023.
Melissa S Anderson, Evelyn W Mahugu, Hayley R Ashbaugh, Aaron G Wellbrock, Maia Nozadze

Emerg Infect Dis· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Partial Lipodystrophy Affecting the Extremities in a Young Woman With Autoimmune Polyglandular Syndrome 1.
Shubham Agarwal, Aaron Bodansky, Chao Xing, Mark S Anderson, Abhimanyu Garg

JCEM Case Rep· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mass balance and pharmacokinetic characterization of zavegepant in healthy male subjects.
Rajinder Bhardwaj, Mary Donohue, Jennifer Madonia, Matt S Anderson, Kyle Matschke

Clin Transl Sci· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular Characterization of Noroviruses Causing Acute Gastroenteritis Outbreaks among US Military Recruits, 2013-2023.
Melissa S Anderson, Chanel A Mosby-Tourtellot, Regina Z Cer, Daniel J Crouch, Ryan S Underwood

Emerg Infect Dis· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial of pembrolizumab, ipilimumab, and aspirin in melanoma: clinical outcomes and translational predictors of response.
Zoe Quandt, Saya Jacob, Muhammad Zaki Hidayatullah Fadlullah, Chaorong Wu, Clinton Wu, Mark S Anderson

BJC Rep· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis